The store will not work correctly when cookies are disabled.
3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-N-(3-iodophenyl)propanamide
ID: ALA4514576
PubChem CID: 155539188
Max Phase: Preclinical
Molecular Formula: C16H15BINO3
Molecular Weight: 407.02
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCc1cccc2c1B(O)OC2)Nc1cccc(I)c1
Standard InChI: InChI=1S/C16H15BINO3/c18-13-5-2-6-14(9-13)19-15(20)8-7-11-3-1-4-12-10-22-17(21)16(11)12/h1-6,9,21H,7-8,10H2,(H,19,20)
Standard InChI Key: SXDDHWQWVZNRNX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
37.3871 -23.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3860 -23.9072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0940 -24.3162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0923 -22.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8009 -23.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8057 -23.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5857 -24.1511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0631 -23.4860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.5780 -22.8266 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
39.8259 -22.0480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0898 -21.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3809 -21.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3785 -20.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6695 -20.2315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0849 -20.2273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9630 -20.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2575 -20.2316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5515 -20.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5535 -21.4597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2674 -21.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9704 -21.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8427 -20.2348 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 407.02 | Molecular Weight (Monoisotopic): 407.0190 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Zhang J, Zhang J, Hao G, Xin W, Yang F, Zhu M, Zhou H.. (2019) Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents., 62 (14): [PMID:31264855] [10.1021/acs.jmedchem.9b00736] |